Joey Sze Yun Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joey Sze Yun Lim has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Bee Luan Khoo
Department of Biomedical Engineering College of Biomedicine City University of Hong Kong Hong Kong China
1 shared publication - Constantine Nicholas Tzouanas
Broad Institute of MIT and Harvard; Cambridge, MA 02139, USA
1 shared publication - Jean Paul Thiery
Guangzhou laboratory, International BioIsland
1 shared publication - Ya Wen
Plug and Play Tech Center, Sunnyvale, CA 94043, USA
1 shared publication
Latest Publications
- Open Access
- 19 November 2017
- Published by MDPI AG in Chemosensors
- Vol. 5 (4) , 30
Microdevices for Non-Invasive Detection of Bladder Cancer
Bladder cancer holds the record for the highest lifetime cost on a per-patient basis. This is due to high recurrence rates, which necessitate invasive and costly long-term evaluation methods such as cystoscopy and imaging. Microfluidics is emerging as an important approach to contribute to initial diagnosis and follow-up, by enabling the precise manipulation of biological samples. Specifically, microdevices have been used for the isolation of cells or genetic material from blood samples, sparking significant interest as a versatile platform for non-invasive bladder cancer detection with voided urine. In this review, we revisit the methods of bladder cancer detection and describe various types of markers currently used for evaluation. We detail cutting-edge technologies and evaluate their merits in the detection, screening, and diagnosis of bladder cancer. Advantages of microscale devices over standard methods of detection, as well as their limitations, are provided. We conclude with a discussion of criteria for guiding microdevice development that could deepen our understanding of prognoses at the level of individual patients and the underlying biology of bladder cancer development. Collectively, the development and widespread application of improved microfluidic devices for bladder cancer could drive treatment breakthroughs and establish widespread, tangible outcomes on patients’ long-term survival.
- 19 November 2017
- Published by MDPI AG in Chemosensors
- Vol. 5 (4) , 30
Open AccessMicrodevices for Non-Invasive Detection of Bladder Cancer
Bladder cancer holds the record for the highest lifetime cost on a per-patient basis. This is due to high recurrence rates, which necessitate invasive and costly long-term evaluation methods such as cystoscopy and imaging. Microfluidics is emerging as an important approach to contribute to initial diagnosis and follow-up, by enabling the precise manipulation of biological samples. Specifically, microdevices have been used for the isolation of cells or genetic material from blood samples, sparking significant interest as a versatile platform for non-invasive bladder cancer detection with voided urine. In this review, we revisit the methods of bladder cancer detection and describe various types of markers currently used for evaluation. We detail cutting-edge technologies and evaluate their merits in the detection, screening, and diagnosis of bladder cancer. Advantages of microscale devices over standard methods of detection, as well as their limitations, are provided. We conclude with a discussion of criteria for guiding microdevice development that could deepen our understanding of prognoses at the level of individual patients and the underlying biology of bladder cancer development. Collectively, the development and widespread application of improved microfluidic devices for bladder cancer could drive treatment breakthroughs and establish widespread, tangible outcomes on patients’ long-term survival.